Edesa
is a Canada-based biopharmaceutical company that discovers and develops novel therapies for the treatment of inflammatory and immune-related diseases... Read moreEdesa
is a Canada-based biopharmaceutical company that discovers and develops novel therapies for the treatment of inflammatory and immune-related diseases... Read more
News
Mar 31, 2026
Benzinga
Edesa: Edesa Biotech Invited for Oral Showcase at Respiratory Innovation Summit
Mar 26, 2026
GlobeNewswire
Press Release: Edesa : Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 Enrollment
Feb 24, 2026
Investing.com
Edesa: Edesa Biotech stock surges on positive Phase 3 trial data
Feb 13, 2026
Benzinga
Edesa: Edesa Biotech Q1 EPS $(0.28) Beats $(0.45) Es...
Feb 13, 2026
Seeking Alpha
Edesa: Edesa Biotech reports FQ1 net loss of $2.2 million
Dec 19, 2025
Americanbankingnews
Edesa: Zacks Small Cap Comments on Edesa Biotech Q1 Earnings
Nov 18, 2025
Seeking Alpha
Edesa: Edesa Biotech, Inc. (EDSA) Presents at LSX Investival Showcase Europe 2025 - Slideshow
Oct 31, 2025
GlobeNewswire
Press Release: Edesa : Edesa Biotech Announces Upcoming Conference Schedule
Oct 29, 2025
Clinical Trials Arena
Edesa: Edesa Biotech reports positive Phase III results for ARDS treatment
Oct 28, 2025
FierceBiotechIT
Edesa: Edesa claims survival data win for phase 3 respiratory failure trial.
Edesa Competitors
1
2
3
4
5
6
7
8
9
10